Search research articles
Contact Us
Filters
Showing results (101-110 of 394) with videos related to
Page
of 40
Sort By:
The Medical Journal of Australia
|
February 4, 2010
Current concepts in the management of Parkinson disease
Michael W Hayes, Victor S Fung, Thomas E Kimber, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
February 18, 2009
Acceleration patterns of the head and pelvis during gait in older people with Parkinson's disease: a comparison of fallers and nonfallers
Mark D Latt, Hylton B Menz, Victor S Fung, et al.
Current Opinion in Psychiatry
|
August 29, 2020
Updates in technology-based interventions for attention deficit hyperactivity disorder
Choon Guan Lim, Nikki S J Lim-Ashworth, Daniel S S Fung
Journal of Cosmetic Dermatology
|
March 13, 2021
An evaluation of the FDA adverse event reporting system and the potential for reporting bias
Andrew D Monnot, Ernest S Fung, Goli S Compoginis, et al.
JMIR Mental Health
|
October 26, 2019
Web-Based Cognitive Bias Modification Interventions for Psychiatric Disorders: Scoping Review
Melvyn Zhang, Jiangbo Ying, Guo Song, et al.
Stroke
|
October 1, 1994
Tactile extinction and functional status after stroke. A preliminary investigation
L Rose, D A Bakal, T S Fung, et al.
Immunotherapy
|
July 11, 2023
An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic
Gordon Taylor Moffat, Lilian Hanna, Wilma Hopman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1991
Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro
S Chung, S Sinclair, J Leibowitz, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1996
Rapid emergence of penicillin-resistant pneumococci in Hong Kong
D J Lyon, O Scheel, K S Fung, et al.
Cancer Treatment and Research Communications
|
January 6, 2023
A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemic
Lilian Hanna, Gordon Taylor Moffat, Wilma Hopman, et al.
Page
of 40
Search research articles
Search
Showing results (101-110 of 394) with videos related to
Sort By:
Page
of 40
The Medical Journal of Australia
|
February 4, 2010
Current concepts in the management of Parkinson disease
Michael W Hayes, Victor S Fung, Thomas E Kimber, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
February 18, 2009
Acceleration patterns of the head and pelvis during gait in older people with Parkinson's disease: a comparison of fallers and nonfallers
Mark D Latt, Hylton B Menz, Victor S Fung, et al.
Current Opinion in Psychiatry
|
August 29, 2020
Updates in technology-based interventions for attention deficit hyperactivity disorder
Choon Guan Lim, Nikki S J Lim-Ashworth, Daniel S S Fung
Journal of Cosmetic Dermatology
|
March 13, 2021
An evaluation of the FDA adverse event reporting system and the potential for reporting bias
Andrew D Monnot, Ernest S Fung, Goli S Compoginis, et al.
JMIR Mental Health
|
October 26, 2019
Web-Based Cognitive Bias Modification Interventions for Psychiatric Disorders: Scoping Review
Melvyn Zhang, Jiangbo Ying, Guo Song, et al.
Stroke
|
October 1, 1994
Tactile extinction and functional status after stroke. A preliminary investigation
L Rose, D A Bakal, T S Fung, et al.
Immunotherapy
|
July 11, 2023
An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic
Gordon Taylor Moffat, Lilian Hanna, Wilma Hopman, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1991
Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro
S Chung, S Sinclair, J Leibowitz, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1996
Rapid emergence of penicillin-resistant pneumococci in Hong Kong
D J Lyon, O Scheel, K S Fung, et al.
Cancer Treatment and Research Communications
|
January 6, 2023
A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemic
Lilian Hanna, Gordon Taylor Moffat, Wilma Hopman, et al.
Page
of 40